Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Avian Flu Vaccine with Longer Protection in Development

A biotechnology company is designing a vaccine to protect against the newly emergent avian flu to provide more sustained protection like seasonal flu vaccines. . . . → Read More: Avian Flu Vaccine with Longer Protection in Development

Drug Delivery Technology Licensed in $2B Deals

The biotechnology company Halozyme Therapeutics Inc. is licensing its technology for making infusion drugs deliverable with injections to two more drug makers. . . . → Read More: Drug Delivery Technology Licensed in $2B Deals

Trial Shows Antibody Effective Against Asthma

Results from a large-scale clinical trial show a synthetic antibody, when added to standard treatments, reduces asthma attacks and improves lung functioning. . . . → Read More: Trial Shows Antibody Effective Against Asthma

NIH Funds Heart Tissue Regeneration Tests in Pigs

An experimental drug to help grow new heart tissue after a heart attack is advancing to tests in pigs, with help from National Institutes of Health. . . . → Read More: NIH Funds Heart Tissue Regeneration Tests in Pigs

Start-Up Lands $10M for Gene-Editing HIV Treatments

A new enterprise developing treatments using gene editing to eliminate HIV infections received $10 million in its seed funding round. . . . → Read More: Start-Up Lands $10M for Gene-Editing HIV Treatments

Engineered T-Cell Trials Stopped after Patient Death

The Food and Drug Administration stopped two clinical trials testing genetically engineered T-cells from the immune system to treat leukemia, after a participant in one trial died. . . . → Read More: Engineered T-Cell Trials Stopped after Patient Death

Trial Underway Testing Alzheimer’s-Schizophrenia Drug

A new clinical trial began in the U.K. in a test of an experimental drug to treat schizophrenia associated with Alzheimer’s disease. . . . → Read More: Trial Underway Testing Alzheimer’s-Schizophrenia Drug

Simple Cell Programming Designed for Gene Therapies

A simpler technique using nanoscale particles was shown in lab tests to deliver messenger RNA to reprogram cells for gene therapies, including changes in T-cells in the immune system now approved to treat a type of leukemia. . . . → Read More: Simple Cell Programming Designed for Gene Therapies

Trial Testing Nicotine Patch for Lung Inflammation

A clinical trial is underway testing a nicotine patch worn to help stop smoking as a treatment for a chronic inflammatory disease affecting the lungs. . . . → Read More: Trial Testing Nicotine Patch for Lung Inflammation

Engineered T-Cell Company Acquired for $11.9 Billion

A company developing personal cancer therapies that genetically engineer a patient’s immune system cells is being acquired in a deal valued at $11.9 billion. . . . → Read More: Engineered T-Cell Company Acquired for $11.9 Billion